TSE:BLU

BELLUS Health (BLU) Stock Forecast, Price & News

C$19.63

-0.21 (-1.06%)

(As of 06/1/2023 ET)

Compare

Today's Range: C$19.62
▼
C$19.84
50-Day Range: C$8.68
▼
C$19.84
52-Week Range: C$8.58
▼
C$19.90

Volume: 17,033 shs
Average Volume: 58,718 shs
Market Capitalization: C$2.49 billion

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: C$20.00

Profile Analyst Ratings Chart Competitors Earnings Insider Trades Headlines Social Media

About BELLUS Health (TSE:BLU) Stock

BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of RCC and chronic pruritus. The company was incorporated in 1993 and is based in Laval, Canada.

Receive BLU Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BELLUS Health and its competitors with MarketBeat's FREE daily newsletter.

BLU Stock News Headlines

April 27, 2023 | theglobeandmail.com

Closing Bell: Bellus Health Inc down on Thursday (BLU)

April 24, 2023 | theglobeandmail.com

Closing Bell: Bellus Health Inc down on Monday (BLU)

June 1, 2023 | UNKNOWN (Ad)

Lithium Has Boomed And This American Stock Is Ready..

Lithium Has Been On A Crazy Rally Over The Last 3 Year's And This Stock Could Be Next!

April 23, 2023 | americanbankingnews.com

Brokers Set Expectations for BELLUS Health Inc.'s Q1 2023 Earnings (TSE:BLU)

April 21, 2023 | theglobeandmail.com

Closing Bell: Bellus Health Inc up on Friday (BLU)

April 20, 2023 | benzinga.com

BELLUS Health Stock (NASDAQ:BLU), Short Interest Report

April 19, 2023 | americanbankingnews.com

Lifesci Capital Downgrades BELLUS Health (TSE:BLU) to Market Perform

April 18, 2023 | benzinga.com

Moore Kuehn Encourages RXDX, STSA, CHRA, and BLU Investors to Contact Law Firm

June 1, 2023 | Vantage Point (Ad)

Instantly Find Hidden Trade Opportunities

There’s a tool that scans and picks the best stocks…how you approach the trades is up to you. But when you’re forecasting 1 – 3 days in advance, it’s not really a guessing game. Stop guessing and start predicting to add consistency to your trades… no matter what happens in the market.

April 18, 2023 | markets.businessinsider.com

Canadian Market Modestly Higher; Bellus Health Soars On Acquisition News

April 18, 2023 | finance.yahoo.com

GSK reaches agreement to acquire late-stage biopharmaceutical company BELLUS Health

April 18, 2023 | theglobeandmail.com

GSK plans to buy Canada-based drug developer Bellus Health for $2-billion

April 18, 2023 | proactiveinvestors.com

GSK pays £1.6bn for Canada's Bellus Health

April 18, 2023 | msn.com

GSK bets $2 billion on Bellus cough drug to soothe pipeline fears

April 18, 2023 | msn.com

Bellus surges ~100% after GSK reaches deal to acquire cough drugmaker for ~$2B

April 18, 2023 | msn.com

GSK to Acquire Bellus Health for $2 Billion

April 18, 2023 | msn.com

GSK to acquire Canada’s Bellus Health for $14.75 per share

April 6, 2023 | theglobeandmail.com

Closing Bell: Bellus Health Inc down on Wednesday (BLU)

March 25, 2023 | americanbankingnews.com

Brokers Issue Forecasts for BELLUS Health Inc.'s FY2027 Earnings (TSE:BLU)

March 24, 2023 | americanbankingnews.com

HC Wainwright Weighs in on BELLUS Health Inc.'s Q1 2023 Earnings (TSE:BLU)

March 24, 2023 | americanbankingnews.com

Jefferies Financial Group Weighs in on BELLUS Health Inc.'s Q1 2023 Earnings (TSE:BLU)

March 6, 2023 | msn.com

4 Biotech Stocks That Could Break Through the Market

March 1, 2023 | finance.yahoo.com

BELLUS Health to Participate in the Cowen 43rd Annual Health Care Conference

February 1, 2023 | markets.businessinsider.com

TSX Recovers After Mid-session Setback, Ends Just Marginally Down

January 20, 2023 | markets.businessinsider.com

TSX Rises 0.8%, Ends At 1-month High

December 20, 2022 | markets.businessinsider.com

Analysts Offer Insights on Healthcare Companies: Innate Pharma SA (OtherIPHYF) and BELLUS Health (BLU)

December 16, 2022 | markets.businessinsider.com

Canadian Shares Extending Losses As Growth Worries Weight On Sentiment

See More Headlines

BLU Price History

30 days | 90 days | 365 days | Advanced Chart

BLU Company Calendar

Last Earnings: 3/21/2023
Today: 6/01/2023
Next Earnings (Estimated): 8/09/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: TSE
Industry: Biotechnology
Sub-Industry: N/A
Sector: Medical
Current Symbol: TSE:BLU
CUSIP: N/A
CIK: N/A
Web: www.bellushealth.com
Phone: +1-450-6804500
Fax: N/A
Employees: 40
Year Founded: N/A

Price Target and Rating

Average Stock Price Forecast: C$20.00
High Stock Price Forecast: C$24.00
Low Stock Price Forecast: C$16.00
Forecasted Upside/Downside: +1.9%
Consensus Rating: Moderate Buy
Rating Score (0-4): 2.67
Research Coverage: 3 Analysts

Profitability

EPS (Most Recent Fiscal Year): C($0.99)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: C$-86,790,000.00
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: -26.76%
Return on Assets: -16.70%

Debt

Debt-to-Equity Ratio: 0.32
Current Ratio: 33.42
Quick Ratio: 16.40

Sales & Book Value

Annual Sales: C$16,000.00
Price / Sales: 155,567.75
Cash Flow: C$4.20 per share
Price / Cash Flow: 4.67
Book Value: C$2.91 per share
Price / Book: 6.75

Miscellaneous

Outstanding Shares: 126,800,000
Free Float: N/A
Market Cap: C$2.49 billion
Optionable: Not Optionable
Beta: -0.33

Key Executives

Mr. Roberto Francesco Bellini (Age 43)
Pres, CEO & Director
Comp: $353.03k

Mr. Ramzi Benamar (Age 50)
Chief Financial Officer
Comp: $607.33k

Dr. Denis Garceau (Age 66)
Chief Scientific Officer
Comp: $431.87k

Mr. Tony Matzouranis (Age 50)
Sr. VP of Bus. Devel.
Comp: $272.89k

Dr. Catherine M. Bonuccelli M.D. (Age 65)
Chief Medical Officer
Comp: $703.77k

Dr. Andreas Orfanos FFPM (Age 64)
M.B.B.Ch, MBA, Chief Operating Officer

Mr. Daniel Matthews
Director of Investor Relations & Communications

Mr. Sebastien Roy (Age 47)
Corp. Sec.

Key Competitors

View All Competitors

Insiders

View All Insider Transactions

BLU Stock - Frequently Asked Questions

Should I buy or sell BELLUS Health stock right now?: 3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for BELLUS Health in the last year. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" BLU shares.
View BLU analyst ratings or view top-rated stocks.
What is BELLUS Health's stock price forecast for 2023?: 3 brokers have issued twelve-month price objectives for BELLUS Health's stock. Their BLU share price forecasts range from C$16.00 to C$24.00. On average, they expect the company's share price to reach C$20.00 in the next year. This suggests a possible upside of 1.9% from the stock's current price.
View analysts price targets for BLU or view top-rated stocks among Wall Street analysts.
How have BLU shares performed in 2023?: BELLUS Health's stock was trading at C$11.08 on January 1st, 2023. Since then, BLU shares have increased by 77.2% and is now trading at C$19.63.
View the best growth stocks for 2023 here.
When is BELLUS Health's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Wednesday, August 9th 2023.
View our BLU earnings forecast.
How were BELLUS Health's earnings last quarter?: BELLUS Health Inc. (TSE:BLU) posted its earnings results on Tuesday, March, 21st. The company reported ($0.19) earnings per share (EPS) for the quarter. The firm earned $0.01 million during the quarter, compared to analyst estimates of $0.01 million.

What other stocks do shareholders of BELLUS Health own?: Based on aggregate information from My MarketBeat watchlists, some companies that other BELLUS Health investors own include Exxon Mobil (XOM), Bombardier (BDRBF), AbbVie (ABBV), Energy Transfer (ET), General Electric (GE), Coca-Cola (KO), Alexion Pharmaceuticals (ALXN), Advanced Micro Devices (AMD), Boeing (BA) and Walt Disney (DIS).
What is BELLUS Health's stock symbol?: BELLUS Health trades on the Toronto Stock Exchange (TSX) under the ticker symbol "BLU."
How do I buy shares of BELLUS Health?: Shares of BLU stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.
What is BELLUS Health's stock price today?: One share of BLU stock can currently be purchased for approximately C$19.63.
How much money does BELLUS Health make?: BELLUS Health (TSE:BLU) has a market capitalization of C$2.49 billion and generates C$16,000.00 in revenue each year. The company earns C$-86,790,000.00 in net income (profit) each year or C($0.99) on an earnings per share basis.
How can I contact BELLUS Health?: BELLUS Health's mailing address is 9-275 Armand-Frappier Blvd, LAVAL, QC H7V 4A7, Canada. The official website for the company is www.bellushealth.com. The company can be reached via phone at +1-450-6804500.

This page (TSE:BLU) was last updated on 6/1/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

BELLUS Health (BLU) Stock Forecast, Price & News

About BELLUS Health (TSE:BLU) Stock

BLU Stock News Headlines

BLU Price History

BLU Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Insiders

BLU Stock - Frequently Asked Questions

About MarketBeat

Popular Tools

Financial Calendars

Terms & Info